James Wangi

Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study

Charmie Godornes, Wendy Houinei, Raymond Paru et al. · The Lancet · 2018 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8

Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigation

Mathew A. Beale, Marc Noguera-Julián, Charmie Godornes et al. · The Lancet Microbe · 2020 · 32 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication

Lucy N. John, Camila González-Beiras, Wendy Houinei et al. · New England Journal of Medicine · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Infectious Disease Pharmacotherapy +1

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

Moses Laman, Livingstone Tavul, Stephan Karl et al. · The Lancet Infectious Diseases · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

Livingstone Tavul, Moses Laman, Cade Howard et al. · PLoS neglected tropical diseases · 2022 · 26 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +14